BUHLMANN Diagnostics Corp
BÜHLMANN is proud to introduce its affiliate BUHLMANN Diagnostics Corp (BDC), serving US and Canadian customers. The Swiss based BÜHLMANN Group presents this year the first fecal calprotectin assay for clinical chemistry instruments, the BÜHLMANN fCAL® turbo (RUO). On the Quantum Blue® Reader, rapid and quantitative fecal and serum calprotectin and the new Infliximab assay are available (all RUO). Another novelty is the new BÜHLMANN GanglioCombi™ MAG ELISA (RUO).
Countries of Interest: Canada, Mexico, United States